| Bioactivity | CDD3505 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity. | ||||||||||||
| Invitro | CDD3505 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol[1]. | ||||||||||||
| Name | CDD3505 | ||||||||||||
| CAS | 173865-33-3 | ||||||||||||
| Formula | C22H17N3O2 | ||||||||||||
| Molar Mass | 355.39 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733 |